It has recently been reported that the overexpression of ESRRA promotes in vitro cell proliferation and malignant growth capacities of cells from prostate cancer cell lines LNCaP and PC-3 under both normal and hypoxic conditions19. The gene discussed is ESRRA; the disease is prostate carcinoma.